Table 2.
Number of studies examining this aspect | |||||
---|---|---|---|---|---|
1981–1989 (N = 2) | 1990–1999 (N = 12) | 2000–2009 (N = 26) | 2010–Aug 2021 (N = 113) | Total 1981–Aug 2021 (N = 153) | |
Types of violations | |||||
Provision of information and education (Art. 4) | |||||
Public | 1 | 7 | 7 | 44 | 59 |
Health workers | 0 | 5 | 6 | 21 | 32 |
Promotion to general public and mothers (Art. 5) | |||||
Shops | 0 | 5 | 8 | 56 | 69 |
Advertisement and promotion on other platforms | 1 | 8 | 16 | 71 | 96 |
Free sample and gifts | 1 | 11 | 10 | 55 | 77 |
Contact with women (Art. 8) | 1 | 3 | 7 | 38 | 49 |
Marketing activities in health care settings and through health workers (Art. 6 and 7) | |||||
Health care systems | 2 | 8 | 13 | 41 | 64 |
Health workers | 0 | 11 | 12 | 44 | 67 |
Free or low‐cost supplies | 0 | 6 | 8 | 20 | 34 |
Conflicts of interest (Res. 49.15 and 58.32) | 1 | 3 | 5 | 12 | 21 |
Violations in labelling and packaging (Art. 9 and 10) | |||||
Labelling | 0 | 6 | 12 | 68 | 86 |
Nutrition and health claims (Res. 58.32 and 63.23) | 0 | 5 | 7 | 54 | 66 |
Inappropriate marketing concerning CF (Res. 69.9) | |||||
Inappropriate messaging and conflicts of interest in health systems | 0 | 5 | 4 | 28 | 37 |
Cross‐promoting products | |||||
Cross‐promotion across BMS and with CF (Res. 69.9) | 0 | 5 | 6 | 43 | 54 |
Abbreviations: BMS, breastmilk substitutes; CF, complementary foods.